The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease

International Journal of Cardiology

Volumn 145, Issue 2, 2010, Pages 172-176

  Ukena, Christian ^a   Mahfoud, Felix ^a   Kindermann, Michael ^a   Kindermann, Ingrid ^a   Bals, Robert ^a   Voors, Adriaan A ^b   Van Veldhuisen, Dirk J ^b   Böhm, Michael ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

C reactive protein; Chronic obstructive pulmonary disease; Chronic systemic inflammatory syndrome; Coronary artery disease; Systemic inflammation

Indexed keywords

C REACTIVE PROTEIN; DIURETIC AGENT; FLUTICASONE; GAMMA INTERFERON; INTERLEUKIN 6; SALMETEROL; STATIN; TIOTROPIUM BROMIDE; TUMOR NECROSIS FACTOR ALPHA;

ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL TRIAL; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE COURSE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEMATOCRIT; HUMAN; IMMUNOCOMPETENT CELL; OBESITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SMOKING CESSATION; TOTAL LUNG CAPACITY;

ANIMALS; CORONARY ARTERY DISEASE; HEART FAILURE; HUMANS; INFLAMMATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 77955560406     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.04.082     Document Type: Review

References (71)

1. R. Horton The neglected epidemic of chronic disease Lancet 366 2005 1514
2. C.M. Boyd, J. Darer, C. Boult, L.P. Fried, L. Boult, and A.W. Wu Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance Jama 294 2005 716 724
3. M. Charlson, R.E. Charlson, W. Briggs, and J. Hollenberg Can disease management target patients most likely to generate high costs? The impact of comorbidity J Gen Intern Med 22 2007 464 469
4. F.H. Rutten, M.J. Cramer, J.W. Lammers, D.E. Grobbee, and A.W. Hoes Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 8 2006 706 711
5. F. Haddad, R. Doyle, D.J. Murphy, and S.A. Hunt Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure Circulation 117 2008 1717 1731 (Pubitemid 351482595)
6. R.P. Young, R. Hopkins, and T.E. Eaton Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes Eur Respir J 30 2007 616 622
7. D.D. Sin, L. Wu, and S.F. Man The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature Chest 127 2005 1952 1959
8. D.J. Hole, G.C. Watt, G. Davey-Smith, C.L. Hart, C.R. Gillis, and V.M. Hawthorne Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study Bmj 313 1996 711 715
9. R. Sabit, C.E. Bolton, and P.H. Edwards Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease Am J Respir Crit Care Med 175 2007 1259 1265
10. T.H. Le Jemtel, M. Padeletti, and S. Jelic Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure J Am Coll Cardiol 49 2007 171 180
11. S.M. Curkendall, C. DeLuise, and J.K. Jones Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients Ann Epidemiol 16 2006 63 70
12. D.M. Mannino, and D.E. Doherty A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study Respir Med 100 2006 115 122
13. P.M. Calverley, J.A. Anderson, and B. Celli Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Engl J Med 356 2007 775 789
14. N.M. Hawkins, M.C. Petrie, P.S. Jhund, G.W. Chalmers, F.G. Dunn, and J.J. McMurray Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology Eur J Heart Fail 11 2009 130 139
15. L. Staszewsky, M. Wong, and S. Masson Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial J Card Fail 13 2007 797 804
16. L.M. Fabbri, F. Luppi, B. Beghe, and K.F. Rabe Complex chronic comorbidities of COPD Eur Respir J 31 2008 204 212
17. M. John, S. Hoernig, W. Doehner, D.D. Okonko, C. Witt, and S.D. Anker Anemia and inflammation in COPD Chest 127 2005 825 829
18. K.F. Rabe, S. Hurd, and A. Anzueto Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 2007 532 555
19. B.R. Celli, C.G. Cote, and J.M. Marin The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease N Engl J Med 350 2004 1005 1012
20. L.M. Fabbri, and K.F. Rabe From COPD to chronic systemic inflammatory syndrome? Lancet 370 2007 797 799
21. D.G. Yanbaeva, M.A. Dentener, E.C. Creutzberg, G. Wesseling, and E.F. Wouters Systemic effects of smoking Chest 131 2007 1557 1566
22. M.J. Sevenoaks, and R.A. Stockley Chronic obstructive pulmonary disease, inflammation and co-morbidity - a common inflammatory phenotype? Respir Res 7 2006 70
23. S.H. Lee, S. Goswami, and A. Grudo Antielastin autoimmunity in tobacco smoking-induced emphysema Nat Med 13 2007 567 569
24. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
25. R. Ross Atherosclerosis - an inflammatory disease N Engl J Med 340 1999 115 126
26. S. Stemme, B. Faber, J. Holm, O. Wiklund, J.L. Witztum, and G.K. Hansson T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein Proc Natl Acad Sci U S A 92 1995 3893 3897
27. J. Frostegard, A.K. Ulfgren, and P. Nyberg Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines Atherosclerosis 145 1999 33 43
28. G. Liuzzo, L.M. Biasucci, and J.R. Gallimore The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424
29. G. Liuzzo, L.M. Biasucci, and A.G. Rebuzzi Plasma protein acute-phase response in unstable angina is not induced by ischemic injury Circulation 94 1996 2373 2380
30. G. Caligiuri, G. Paulsson, A. Nicoletti, A. Maseri, and G.K. Hansson Evidence for antigen-driven T-cell response in unstable angina Circulation 102 2000 1114 1119
31. G.A. MacGowan, D.L. Mann, R.L. Kormos, A.M. Feldman, and S. Murali Circulating interleukin-6 in severe heart failure Am J Cardiol 79 1997 1128 1131
32. K. Maeda, T. Tsutamoto, and A. Wada High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure J Am Coll Cardiol 36 2000 1587 1593
33. J.L. Alonso-Martinez, B. Llorente-Diez, M. Echegaray-Agara, F. Olaz-Preciado, M. Urbieta-Echezarreta, and C. Gonzalez-Arencibia C-reactive protein as a predictor of improvement and readmission in heart failure Eur J Heart Fail 4 2002 331 336
34. V. Vila, V. Martinez-Sales, L. Almenar, I.S. Lazaro, P. Villa, and E. Reganon Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients Int J Cardiol 130 2008 276 277
35. Y. Seta, K. Shan, B. Bozkurt, H. Oral, and D.L. Mann Basic mechanisms in heart failure: the cytokine hypothesis J Card Fail 2 1996 243 249
36. P.C. Colombo, D. Onat, and H.N. Sabbah Acute heart failure as "acute endothelitis" - interaction of fluid overload and endothelial dysfunction Eur J Heart Fail 10 2008 170 175
37. D.L. Mann, J.J. McMurray, and M. Packer Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
38. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, and M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
39. S.D. Anker, W. Steinborn, and S. Strassburg Cardiac cachexia Ann Med 36 2004 518 529
40. A. Vaz Perez, W. Doehner, and S. von Haehling The relationship between tumor necrosis factor-alpha, brain natriuretic peptide and atrial natriuretic peptide in patients with chronic heart failure Int J Cardiol 2009
41. E. Eleuteri, F. Magno, and I. Gnemmi Role of oxidative and nitrosative stress biomarkers in chronic heart failure Front Biosci 14 2009 2230 2237
42. S.K. Venugopal, S. Devaraj, and I. Jialal Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role Curr Opin Nephrol Hypertens 14 2005 33 37
43. J.A. Wedzicha, T.A. Seemungal, and P.K. MacCallum Acute exacerbations of chronic obstructive pulmonary disease are accompanied by elevations of plasma fibrinogen and serum IL-6 levels Thromb Haemost 84 2000 210 215
44. D.D. Sin, and S.F. Man Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease Circulation 107 2003 1514 1519
45. L. Smeeth, S.L. Thomas, A.J. Hall, R. Hubbard, P. Farrington, and P. Vallance Risk of myocardial infarction and stroke after acute infection or vaccination N Engl J Med 351 2004 2611 2618
46. K. Dickstein, A. Cohen-Solal, and G. Filippatos ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur J Heart Fail 10 2008 933 989
47. N.R. Anthonisen, M.A. Skeans, R.A. Wise, J. Manfreda, R.E. Kanner, and J.E. Connett The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial Ann Intern Med 142 2005 233 239
48. J.A. Critchley, and S. Capewell Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review Jama 290 2003 86 97
49. W.B. Kannel, J.F. Plehn, and L.A. Cupples Cardiac failure and sudden death in the Framingham Study Am Heart J 115 1988 869 875
50. N. Suskin, T. Sheth, A. Negassa, and S. Yusuf Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction J Am Coll Cardiol 37 2001 1677 1682
51. G.B. Mancini, M. Etminan, B. Zhang, L.E. Levesque, J.M. FitzGerald, and J.M. Brophy Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease J Am Coll Cardiol 47 2006 2554 2560
52. G.B. Mancini Clarion call for trials assessing " cardiopulmonary" agents to reduce morbidity and mortality in inflammatory lung diseases Chest 131 2007 950 951
53. H.J. Dargie Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 2001 1385 1390
54. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial Lancet 353 1999 9 13
55. S.S. Salpeter, T. Ormiston, E. Salpeter, P. Poole, and C. Cates Cardioselective beta-blockers for chronic obstructive pulmonary disease Cochrane Database Syst Rev 2002 CD003566
56. S. Andreas, S.D. Anker, P.D. Scanlon, and V.K. Somers Neurohumoral activation as a link to systemic manifestations of chronic lung disease Chest 128 2005 3618 3624
57. H.J. van der Woude, J. Zaagsma, D.S. Postma, T.H. Winter, M. van Hulst, and R. Aalbers Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers Chest 127 2005 818 824
58. M. Lainscak, L.M. Hodoscek, and H.D. Dungen The burden of chronic obstructive pulmonary disease in patients hospitalized with heart failure Wien Klin Wochenschr 121 2009 309 313
59. S.R. Salpeter, T.M. Ormiston, and E.E. Salpeter Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis Chest 125 2004 2309 2321
60. M. Cazzola, F. Imperatore, and A. Salzillo Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia Chest 114 1998 411 415
61. S. Singh, Y.K. Loke, and C.D. Furberg Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis Jama 300 2008 1439 1450
62. D. Fliser, K. Buchholz, and H. Haller Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation Circulation 110 2004 1103 1107
63. C. Werner, M. Baumhakel, and K.K. Teo RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection Clin Res Cardiol 97 2008 418 431
64. S. Andreas, C. Herrmann-Lingen, and T. Raupach Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial Eur Respir J 27 2006 972 979 (Pubitemid 44911111)
65. O. Adam, and U. Laufs Antioxidative effects of statins Arch Toxicol 2008
66. S.E. Alexeeff, A.A. Litonjua, D. Sparrow, P.S. Vokonas, and J. Schwartz Statin use reduces decline in lung function: VA Normative Aging Study Am J Respir Crit Care Med 176 2007 742 747
67. F.J. Frost, H. Petersen, K. Tollestrup, and B. Skipper Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins Chest 131 2007 1006 1012
68. P. van der Harst, M. Bohm, W.H. van Gilst, and D.J. van Veldhuisen The case for statin therapy in chronic heart failure Clin Res Cardiol 97 2008 139 146 (Pubitemid 351712813)
69. I. Gissi-Hf Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 2008
70. J. Kjekshus, E. Apetrei, and V. Barrios Rosuvastatin in older patients with systolic heart failure N Engl J Med 357 2007 2248 2261
71. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150